James McIntyre
Research Professor
Last active: 7/25/2014


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Synthesis and in vitro efficacy of MMP9-activated NanoDendrons. Samuelson LE, Scherer RL, Matrisian LM, McIntyre JO, Bornhop DJ (2013) Mol Pharm 10(8): 3164-74
    › Primary publication · 23750801 (PubMed) · PMC4824186 (PubMed Central)
  2. A novel in vitro assay to assess phosphorylation of 3'-[(18)F]fluoro-3'-deoxythymidine. Guo N, Xie J, Manning HC, Deane NG, Ansari MS, Coffey RJ, Gore J, Price RR, Baldwin RM, McIntyre JO (2011) Mol Imaging Biol 13(2): 257-64
    › Primary publication · 20532643 (PubMed) · PMC4180216 (PubMed Central)
  3. Near-infrared optical proteolytic beacons for in vivo imaging of matrix metalloproteinase activity. McIntyre JO, Scherer RL, Matrisian LM (2010) Methods Mol Biol : 279-304
    › Primary publication · 20135290 (PubMed) · PMC4495730 (PubMed Central)
  4. Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon. Scherer RL, VanSaun MN, McIntyre JO, Matrisian LM (2008) Mol Imaging 7(3): 118-31
    › Primary publication · 19123982 (PubMed) · PMC2777890 (PubMed Central)
  5. Functional colonography of Min mice using dark lumen dynamic contrast-enhanced MRI. Quarles CC, Lepage M, Gorden DL, Fingleton B, Yankeelov TE, Price RR, Matrisian LM, Gore JC, McIntyre JO (2008) Magn Reson Med 60(3): 718-26
    › Primary publication · 18727087 (PubMed) · PMC2646120 (PubMed Central)
  6. Imaging matrix metalloproteinases in cancer. Scherer RL, McIntyre JO, Matrisian LM (2008) Cancer Metastasis Rev 27(4): 679-90
    › Primary publication · 18465089 (PubMed)
  7. Noninvasive detection of matrix metalloproteinase activity in vivo using a novel magnetic resonance imaging contrast agent with a solubility switch. Lepage M, Dow WC, Melchior M, You Y, Fingleton B, Quarles CC, P├ępin C, Gore JC, Matrisian LM, McIntyre JO (2007) Mol Imaging 6(6): 393-403
    › Primary publication · 18053410 (PubMed)
  8. Proteinase activity in human and murine saliva as a biomarker for proteinase inhibitor efficacy. Fingleton B, Menon R, Carter KJ, Overstreet PD, Hachey DL, Matrisian LM, McIntyre JO (2004) Clin Cancer Res 10(23): 7865-74
    › Primary publication · 15585619 (PubMed)
  9. Molecular imaging of proteolytic activity in cancer. McIntyre JO, Matrisian LM (2003) J Cell Biochem 90(6): 1087-97
    › Primary publication · 14635184 (PubMed)
  10. Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. McIntyre JO, Fingleton B, Wells KS, Piston DW, Lynch CC, Gautam S, Matrisian LM (2004) Biochem J 377(Pt 3): 617-28
    › Primary publication · 14556651 (PubMed) · PMC1223892 (PubMed Central)
  11. (R)-3-hydroxybutyrate dehydrogenase: selective phosphatidylcholine binding by the C-terminal domain. Loeb-Hennard C, McIntyre JO (2000) Biochemistry 39(39): 11928-38
    › Primary publication · 11009606 (PubMed)
  12. Comparison of 3-hydroxybutyrate dehydrogenase from bovine heart and rat liver mitochondria. McIntyre JO, Latruffe N, Brenner SC, Fleischer S (1988) Arch Biochem Biophys 262(1): 85-98
    › Primary publication · 3355176 (PubMed)